Nature Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.33 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 0.50 M
- Revenue Growth %
- Profit Growth -130.03%
- Ebitda 4.89%
- Net Worth -33.75%
- Total Assets -32.71%
About Nature Life Science
Nature Life Science Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 1998 and has a history of 26 years and seven months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.33 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sneha Kulkarni and Rajendra Kulkarni serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85191PN1998PTC012666
- Company No.
012666
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 1998
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Nature Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sneha Kulkarni  | Managing Director | 27-Mar-2000 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajendra Kulkarni | Director | 27-Mar-2000 | Current |
Financial Performance of Nature Life Science.
Nature Life Science Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 130.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nature Life Science?
In 2018, Nature Life Science had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nature Life Remedies Private LimitedSneha Kulkarni and Rajendra Kulkarni are mutual person
Charges (Loans)
₹0
₹0.50 M
Charges Breakdown by Lending Institutions
- Uti Bank Ltd : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2004 | Uti Bank Ltd | ₹0.50 M | Satisfied |
How Many Employees Work at Nature Life Science?
Unlock and access historical data on people associated with Nature Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nature Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nature Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.